Page last updated: 2024-12-06

cyclohept-2-en-1-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyclohept-2-en-1-one: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID70723
SCHEMBL ID446593
MeSH IDM0084637

Synonyms (28)

Synonym
1121-66-0
tropilene
nsc155333
2-cycloheptenone
nsc-155333
2-cyclohepten-1-one
2-cyclohepten-1-one, 80%, technical grade
cyclohept-2-en-1-one
A2240
AKOS005266486
(z)-cyclohept-2-enone
einecs 214-334-1
nsc 155333
cyclohept-2-enone
FT-0633357
S10329
SCHEMBL446593
cyclohept-en-1-one
cycloheptenone
cyclohept-2-eneone
DTXSID30149916
mfcd00004157
J-002719
CS-W007594
DS-18474
C3180
SY041083
EN300-50593
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]